Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy
Clinical trial NCT04957758 · COMPLETED
Trial details
- NCT number
- NCT04957758
- Sponsor
- Oyster Point Pharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-17
- Primary completion
- 2023-01-27
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.